Insulin-Like Growth Factor–Type 1 Receptor Inhibitor NVP-AEW541 Enhances Radiosensitivity of PTEN Wild-Type but Not PTEN-Deficient Human Prostate Cancer Cells (Q39495112)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 1, 2011

Language	Label	Description	Also known as
English	Insulin-Like Growth Factor–Type 1 Receptor Inhibitor NVP-AEW541 Enhances Radiosensitivity of PTEN Wild-Type but Not PTEN-Deficient Human Prostate Cancer Cells	scientific article published on September 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Insulin-Like Growth Factor–Type 1 Receptor Inhibitor NVP-AEW541 Enhances Radiosensitivity of PTEN Wild-Type but Not PTEN-Deficient Human Prostate Cancer Cells (English)

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Johannes V. Swinnen

2

object named as

Johannes V. Swinnen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21816290

8 December 2024

Karin Haustermans

4

object named as

Karin M. Haustermans

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21816290

8 December 2024

author name string

Sofie F. Isebaert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21816290

8 December 2024

William H. McBride

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21816290

8 December 2024

language of work or name

0 references

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0360301611004937?httpAccept=text/xml

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

https://api.elsevier.com/content/article/PII:S0360301611004937?httpAccept=text/plain

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

239-247

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Insulin-Like Growth Factor (IGF) family and prostate cancer

1

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

The role of the IGF system in cancer growth and metastasis: overview and recent insights

2

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer

3

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer

4

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling

5

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway

6

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation

7

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Redundancy of radioresistant signaling pathways originating from insulin-like growth factor I receptor

8

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications

9

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer

10

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

The RAS signal transduction pathway and its role in radiation sensitivity

11

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance.

12

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism

13

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

PTEN function in normal and neoplastic growth

14

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Cancer statistics, 2010

15

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer

16

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer

17

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer

18

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

20

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma

21

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo

22

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion

23

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway

24

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.

25

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

26

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis

27

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation

28

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Radiation-induced EGFR-signaling and control of DNA-damage repair

29

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.

30

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir

31

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation

32

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541.

34

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody

35

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway

36

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance

37

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin

38

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer

39

1 reference

10.1016/J.IJROBP.2011.03.030

https://api.crossref.org/works/10.1016/J.IJROBP.2011.03.030

8 December 2024

Identifiers

10.1016/J.IJROBP.2011.03.030

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39495112&oldid=2285107724"